{
  "author": {
    "name": "Scott Wooldrige",
    "webUrl": "/author/profile/scott-wooldrige/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 3,
    "social": [],
    "articles": [
      {
        "uri": "/2020/12/16/5-new-drugs-coming-down-the-pipeline-in-2021/",
        "title": "5 new drugs coming down the pipeline in 2021",
        "byline": "Scott Wooldrige",
        "kicker": "Market Insights",
        "prettyDate": "December 16, 2020",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/04/DrugVials.jpg",
          "width": "0",
          "height": "0"
        },
        "authors": [
          {
            "webUrl": "/author/profile/scott-wooldrige/",
            "name": "Scott Wooldrige"
          }
        ],
        "kickerNode": [
          {
            "uri": "/market-insights/",
            "sectionName": "Market Insights"
          }
        ],
        "summary": "From prostate cancer to lymphoma, these drugs offer hope for consumers, but they come with hefty price tags.",
        "body": null
      },
      {
        "uri": "/2020/10/28/cancer-related-costs-expected-to-hit-200-billion-this-year/",
        "title": "Cancer-related costs expected to hit $200 billion this year",
        "byline": "Scott Wooldrige",
        "kicker": "Analysis",
        "prettyDate": "October 28, 2020",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/10/DrugPillsMoneyShutterstck.jpg",
          "width": "0",
          "height": "0"
        },
        "authors": [
          {
            "webUrl": "/author/profile/scott-wooldrige/",
            "name": "Scott Wooldrige"
          }
        ],
        "kickerNode": [
          {
            "uri": "/analysis/",
            "sectionName": "Analysis"
          }
        ],
        "summary": "Whether patients will be able to afford the cost of treatment depends largely on what kind of insurance they have.",
        "body": null
      },
      {
        "uri": "/2019/04/29/forget-medicare-for-all-americans-want-help-with-health-care-expenses/",
        "title": "Forget Medicare for All, Americans want help with health care expenses",
        "byline": "Scott Wooldrige",
        "kicker": "Analysis",
        "prettyDate": "April 29, 2019",
        "timeToRead": "3 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/04/healthcaremedicalbillingstethoscopemi6001.jpg",
          "width": "600",
          "height": "338"
        },
        "authors": [
          {
            "webUrl": "/author/profile/scott-wooldrige/",
            "name": "Scott Wooldrige"
          }
        ],
        "kickerNode": [
          {
            "uri": "/analysis/",
            "sectionName": "Analysis"
          }
        ],
        "summary": "Major health care reform is much less of a priority than bringing immediate relief to Americans' pocketbooks. ",
        "body": null
      }
    ]
  }
}